上皮中性粒細胞激活肽78(ENA78)多克隆抗體
Polyclonal Antibody to Epithelial Neutrophil Activating Peptide 78 (ENA78)
CXCL5; SCYB5; Chemokine C-X-C-Motif Ligand 5; Small Inducible Cytokine Subfamily B(Cys-X-Cys),Member 5; Neutrophil-activating peptide ENA-78
- 編號PAA860Hu02
- 物種Homo sapiens (Human,人) 相同的名稱,不同的物種。
- 來源多抗制備
- 宿主兔
- 效價-
- Ig類型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 免疫原 RPA860Hu02-上皮中性粒細胞激活肽78(ENA78)重組蛋白
- 緩沖液成份磷酸鹽緩沖液(pH7.4,含有0.02% NaN3和50%甘油)
- 性狀液體
- 濃度500μg/mL
- 且適物種-
- 應用WB; IHC; ICC; IP.
如果抗體需用于流式細胞術,請參見流式抗體。 - 下載 英文說明書 中文說明書
- 規(guī)格 20μl100μl 200μl 1ml 10ml
- 價格 ¥ 403 ¥ 941 ¥ 1344 ¥ 3360 ¥ 13440
- 欲了解實際交易價格和更多情況,請與當地經銷商聯系!
特異性
該抗體是針對ENA78的兔多克隆抗體。在免疫組織化學染色和免疫印跡實驗中能識別ENA78。
用法
Western blotting: 0.5-2μg/mL
Immunohistochemistry: 5-20μg/mL
Immunocytochemistry: 5-20μg/mL
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過兩年。避免反復凍融。
穩(wěn)定性
熱穩(wěn)定性以損失率顯示。損失率是由加速降解試驗決定,具體方法如下:在37°C孵育48小時,沒有顯著的降解或者沉淀產生。保質期內,在適當的條件下存儲,損失率低于5%。
贈品
增值服務
相關產品
編號 | 適用物種:Homo sapiens (Human,人) | 應用(僅供研究使用,不用于臨床診斷!) |
APA860Hu01 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA860Hu02 | 上皮中性粒細胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
EPA860Hu61 | 上皮中性粒細胞激活肽78(ENA78)真核蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
RPA860Hu03 | 上皮中性粒細胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA860Hu61 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
RPA860Hu01 | 上皮中性粒細胞激活肽78(ENA78)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
APA860Hu02 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
APA860Hu03 | 上皮中性粒細胞激活肽78(ENA78)活性蛋白 | Cell?culture;?Activity?Assays. |
PAA860Hu02 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. |
PAA860Hu03 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. |
PAA860Hu01 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體 | WB; IHC; ICC; IP. |
LAA860Hu81 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體(異硫氰酸熒光素標記) | WB; IHC; ICC; IF. |
LAA860Hu71 | 上皮中性粒細胞激活肽78(ENA78)多克隆抗體(生物素標記) | WB; IHC; ICC. |
MAA860Hu22 | 上皮中性粒細胞激活肽78(ENA78)單克隆抗體 | WB; IHC; ICC; IP. |
SEA860Hu | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antigen Detection. |
AEA860Hu | 抗上皮中性粒細胞激活肽78抗體(Anti-ENA78)檢測試劑盒(酶聯免疫吸附試驗法) | Enzyme-linked immunosorbent assay for Antibody Detection. |
SCA860Hu | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒(化學發(fā)光免疫分析法) | Chemiluminescent immunoassay for Antigen Detection. |
LMA860Hu | 上皮中性粒細胞激活肽78(ENA78)等多因子檢測試劑盒(流式熒光發(fā)光法) | FLIA Kit for Antigen Detection. |
KSA860Hu01 | 上皮中性粒細胞激活肽78(ENA78)檢測試劑盒DIY材料(酶聯免疫吸附試驗法) | Main materials for "Do It (ELISA Kit) Yourself". |
參考文獻
雜志 | 參考文獻 |
Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis. [Pubmed:26862043] |
Journal of Biochemical and Molecular Toxicology | Ameliorative Effects of Curcumin on Fibrinogen-Like Protein-2 Gene Expression, Some Oxido-Inflammatory and Apoptotic Markers in a Rat Model of l-Arginine-Induced Acute Pancreatitis [pubmed:26862043] |
OncoTargets and Therapy | The clinical significance of CXCL5 in non-small cell lung cancer. [pubmed:29200871] |
Biochimie | Activated CXCL5-CXCR2 axis promotes the migration, invasion and EMT of papillary thyroid carcinoma cells via modulation of β-catenin pathway [Pubmed:29471001] |
Cancer?Biology?&?Therapy | Activation of CXCL5-CXCR2 axis promotes proliferation and accelerates G1 to S phase transition of papillary thyroid carcinoma cells and activates JNK and p38?… [Pubmed: 30404567] |
Respiratory?Research | Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from?… [Pubmed: 30634975] |
American Journal of Pathology | Interleukin17–CXCR2 axis facilitates breast cancer progression by up-regulating neutrophil recruitment [Pubmed: 31654638] |
Bioactive Materials | Secretions from hypochlorous acid-treated tumor cells delivered in a melittin hydrogel potentiate cancer immunotherapy [34820587] |
Am J Cancer Res | Differential expression profile of CXC-receptor-2 ligands as potential biomarkers in pancreatic ductal adenocarcinoma [Pubmed:35141005] |
留言咨詢